MHS
PJP icon

M Holdings Securities’s Invesco Pharmaceuticals ETF PJP Stock Holding History

M Holdings Securities’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-255
Closed -$22K – 365
2014
Q3 		$22K Buy
+255
New +$15.7K 0.01% 510

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
FIG
FundX Investment Group San Francisco, California $411M AUM 22.05% 1-Year Est. Return
PFG
Pacific Financial Group Bellevue, Washington $209M AUM 22.2% 1-Year Est. Return
SCM
Summit Capital Management Seattle, Washington $221M AUM 4.14% 1-Year Est. Return

M Holdings Securities's PJP Position: Q4 2014 in Review

M Holdings Securities sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2014, closing a stake of 255 shares — an estimated $22K sold.

M Holdings Securities first reported a position in PJP in Q3 2014 and held it in 1 quarter. The position peaked at $22K in Q3 2014. 97 funds tracked by Wall St. Rank hold PJP as of Q4 2014.

  • M Holdings Securities reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2014 after selling out during the quarter.
  • M Holdings Securities sold 255 Invesco Pharmaceuticals ETF shares in Q4 2014, an estimated $22K.
  • M Holdings Securities first reported a position in Invesco Pharmaceuticals ETF in Q3 2014 and held it in 1 quarter.
  • M Holdings Securities's Invesco Pharmaceuticals ETF position peaked at $22K in Q3 2014.
  • 97 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2014.

Based on M Holdings Securities's 13F filing for Q4 2014, filed 13 Feb 2015.